Drug Profile
Research programme: inducible nitric oxide synthase inhibitor - AlphaRx
Alternative Names: ARX 828; iNOS inhibitors - AlphaRx; NOS 2 inhibitors - AlphaRx; NOS II inhibitors - AlphaRxLatest Information Update: 02 Mar 2011
Price :
$50
*
At a glance
- Originator AlphaRx
- Class
- Mechanism of Action Nitric oxide synthase type II inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammatory bowel diseases; Rheumatoid arthritis
Most Recent Events
- 02 Mar 2011 No development reported - Preclinical for Inflammatory bowel disease in Canada (PO)
- 02 Mar 2011 No development reported - Preclinical for Rheumatoid arthritis in Canada (PO)
- 13 Sep 2007 Preclinical trials in Inflammatory bowel disease in Canada (PO)